MAIMONE, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 2.169
EU - Europa 1.960
AS - Asia 1.039
SA - Sud America 358
AF - Africa 31
OC - Oceania 3
Totale 5.560
Nazione #
US - Stati Uniti d'America 2.144
RU - Federazione Russa 684
SG - Singapore 431
IE - Irlanda 349
CN - Cina 340
BR - Brasile 323
SE - Svezia 298
IT - Italia 216
HK - Hong Kong 128
DE - Germania 112
FI - Finlandia 68
PL - Polonia 62
VN - Vietnam 48
UA - Ucraina 42
GB - Regno Unito 39
IN - India 35
FR - Francia 30
AR - Argentina 16
BE - Belgio 13
CA - Canada 12
NL - Olanda 11
BD - Bangladesh 9
JP - Giappone 9
MX - Messico 9
CI - Costa d'Avorio 8
TR - Turchia 8
ZA - Sudafrica 6
AT - Austria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
EE - Estonia 5
ES - Italia 5
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
CL - Cile 3
ID - Indonesia 3
IL - Israele 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
PY - Paraguay 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 5.560
Città #
Ashburn 484
Moscow 364
Dublin 349
Dallas 348
Singapore 227
Chandler 225
Nyköping 171
Beijing 138
Hong Kong 126
Jacksonville 98
Messina 71
Warsaw 58
The Dalles 57
Ann Arbor 54
Dearborn 48
Munich 46
Princeton 46
Los Angeles 45
Medford 45
Des Moines 37
Cambridge 36
New York 36
Rome 28
Turku 25
São Paulo 22
Nanjing 21
Boardman 20
Buffalo 20
Jinan 20
Helsinki 17
San Mateo 17
Ho Chi Minh City 16
Redondo Beach 15
Shenyang 15
Tianjin 15
Pune 14
Woodbridge 14
Brussels 13
Rio de Janeiro 12
Hanoi 11
Hyderabad 11
Ningbo 11
Nuremberg 11
Wilmington 11
Haikou 10
Houston 10
Avola 9
Belo Horizonte 9
Bremen 9
Brooklyn 9
Düsseldorf 9
Hebei 9
Seattle 9
Abidjan 8
Chicago 8
Guangzhou 8
Orem 8
Tokyo 8
Brasília 7
Catania 7
Frankfurt am Main 7
Zhengzhou 7
Amsterdam 6
Boston 6
Dhaka 6
London 6
Council Bluffs 5
Manchester 5
Porto Alegre 5
Stockholm 5
Brno 4
Campinas 4
Curitiba 4
Dong Ket 4
Goiânia 4
Guarulhos 4
Montreal 4
Nanchang 4
Poplar 4
Querétaro 4
San Francisco 4
Santa Clara 4
Taizhou 4
Toronto 4
Vienna 4
Vittoria 4
Washington 4
Augusta 3
Chennai 3
Conselheiro Lafaiete 3
Dakar 3
Denver 3
Haiphong 3
Hangzhou 3
Jakarta 3
Jiaxing 3
Madrid 3
Maringá 3
Mexico City 3
Milan 3
Totale 3.770
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 337
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 215
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 210
Atrial fibrillation in patients with cirrhosis 191
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 180
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 179
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 168
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 164
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 162
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 154
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 153
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 145
Assessment of liver stifness values in subjects affected by familial combined hyperlipidemia with different degree of hepatic steatosis 142
Erectile dysfunction in compensated liver cirrhosis 139
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 138
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 137
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 129
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 126
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 126
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 121
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 120
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 120
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 118
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 117
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 115
Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices 114
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 112
Response to the high diagnostic characteristics of HBsAg level in differentiation of Hepatitis B clinical presentations: myth or truth? 102
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 101
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 96
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 94
Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient 87
Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis 86
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 86
Coagulation and fibrosis in chronic liver disease 85
Does HCV antiviral therapy decrease the risk of hepatocellular carcinoma? 85
INFECTION WITH HBV PRES/S VARIANTS IS HIGHLY PREVALENT AND INFLUENCES AMOUNT OF CIRCULATING HBSAG INDEPENDENTLY OF SERUM HBV DNA LEVELS AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS B 84
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 77
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 62
The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis 61
Impact of tips preliver transplantation for the outcome posttransplantation 60
Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial] 58
Therapy of occult hepatitis B virus infection and prevention of reactivation. 56
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 56
Models for non-alcoholic fatty liver disease: A link with vascular risk 55
Fibrosis staging in chronic hepatitis C: Analysis of discordance between transient elastography and liver biopsy 46
Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection 41
null 31
null 22
null 15
Totale 5.678
Categoria #
all - tutte 19.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 20 15 31 46 29 15 15
2021/2022351 5 42 12 21 21 2 18 10 2 68 46 104
2022/2023945 71 102 39 60 64 87 19 50 413 4 22 14
2023/2024458 19 33 11 21 20 62 1 221 2 22 8 38
2024/20251.097 24 29 13 68 30 37 46 205 286 78 116 165
2025/20261.961 210 265 311 178 284 713 0 0 0 0 0 0
Totale 5.678